Fabian Yu, MSc, PhD, currently serves as a Medical Advisor for Lung Oncology at AstraZeneca, where responsibilities include directing medical strategy for early-stage non-small cell lung cancer and small cell lung cancer, managing a team of Medical Science Liaisons (MSLs), and supporting clinical trial initiatives. Prior roles include Medical Science Liaison for GU Oncology at Bayer, where relationships with key opinion leaders were developed, and various positions at Ximbio and Postdoc Industry Consultants, involving project leadership and market analysis. Educational qualifications comprise a PhD in Life Sciences from the University of Toronto, an ASCB-KGI certificate in Managing Science in Biotech Industry, and MSc and BScH degrees in Molecular Genetics and Biology from Queen's University, respectively.
This person is not in any teams
This person is not in any offices